Misspelled Author Name

In the Original Investigation titled “Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial,”¹ published online April 30, 2015, the byline contained a typographical error. The name should have appeared as Paolo Nuciforo, MD. This article was corrected online. This article was also corrected on May 22, 2015,² for errors in Figure 2.